Ketone bodies

Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023

Retrieved on: 
Tuesday, August 29, 2023
Epilepsy, Incidence, Seizure, Maintenance, Prednisolone, Hypsarrhythmia, Drug discovery, Spasm, Ketone bodies, Adrenocorticotropic hormone, EMA, Plasma, US, Disorder, Patient, Nature, Risk, Vigabatrin, Epileptic spasms, IND, Caregiver, Safety, SLC6A1 epileptic encephalopathy, Pharmaceutical industry, Dietary supplement

DENVER, Aug. 29, 2023 /PRNewswire/ -- Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, today announced that new data on investigational CER-0001 (tricaprilin) in infantile spasms (also known as West syndrome) has been accepted for presentation at the 35th International Epilepsy Congress, held in Dublin, Ireland from September 2nd-6th 2023.

Key Points: 
  • DENVER, Aug. 29, 2023 /PRNewswire/ -- Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, today announced that new data on investigational CER-0001 (tricaprilin) in infantile spasms (also known as West syndrome) has been accepted for presentation at the 35th International Epilepsy Congress, held in Dublin, Ireland from September 2nd-6th 2023.
  • The presentation title is, "Treatment of Drug-Resistant Infantile Spasms with CER-0001, A Ketogenic Agent: Preliminary Results".
  • Infantile spasms usually affects children under the age of 36 months and can lead to permanent cognitive, neurologic and sensory problems.
  • Infantile spasms patients experience rapid, characteristic muscular contraction or extensions lasting one to two seconds and occurring in clusters ranging from a few spasms to more than 100 spasms per cluster.

Ketone drinks: do they really improve sports performance?

Retrieved on: 
Thursday, July 6, 2023
Taste, Exercise, Tissue, Diet, Magic, Fats, Glucose, Weight loss, Ketone bodies, Brain, Research, Attention, Athlete, McMaster University, Sodium bicarbonate, Blood, Carbohydrate, Ketone, Sport, KU Leuven, Dietary supplement, Animal feed, Asterix

But do they really improve performance?

Key Points: 
  • But do they really improve performance?
  • Ketone bodies can also be used in other tissues, such as muscle, and could eventually be used as fuel during exercise.
  • Initially, most ketone supplements caused gastrointestinal issues and did not sufficiently increase ketone body availability.
  • A newer ketone monoester (ketone body bound to a compound called monoester) drink was shown not to cause gastrointestinal discomfort and to sufficiently increase ketone body concentrations in the blood.

Cerecin received US FDA clearance to study CER-0001 under an Investigational New Drug (IND) application for Infantile Spasms

Retrieved on: 
Wednesday, December 7, 2022
Investigational New Drug, Adrenocorticotropic hormone, Neurology, Hypsarrhythmia, Patient, Epileptic spasms, Ketone bodies, Peripheral nervous system, Incidence, Smart contract, US Foods, Vigabatrin, Spasms, Safety, Migraine, IS, Spasm, Ketosis, Epilepsy, Prednisolone, Disorder, Research, Plasma, IND, Risk, Caregiver, Pharmaceutical industry

The open IND gives Cerecin clearance to proceed with the next phase of the planned development for CER-0001 in IS.

Key Points: 
  • The open IND gives Cerecin clearance to proceed with the next phase of the planned development for CER-0001 in IS.
  • IS usually affects children under the age of 36 months and can lead to cognitive, neurologic and sensory problems.
  • The disorder is commonly treated with hormonal medications (such as adrenocorticotropic hormone and prednisolone) and vigabatrin, an anticonvulsant.
  • Cerecin’s pilot study of CER-0001 is ongoing and will have recruited the 10th and final patient by 1H 2023.

Cerecin Announces Abstract on New Infantile Spasms Data Accepted for Oral Presentation at the International League Against Epilepsy EME Congress 2022

Retrieved on: 
Thursday, November 3, 2022
Migraine, Ketone bodies, Therapy, Epilepsy, Neurology, Congress, GLOBE, Poster, International League Against Epilepsy, Plasma, Peripheral nervous system, Spasm, Pharmaceutical industry

SINGAPORE and DENVER, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Cerecin, Inc. a clinical-stage biotechnology company pioneering innovative neurotherapeutics, today announced that a poster showcasing new data on investigational CER-0001 (tricaprilin) in Infantile Spasms (also known as West Syndrome) has been accepted for virtual oral presentation at the hybrid International League Against Epilepsy EME Congress, held in Riyadh from November 16-19, 2022.

Key Points: 
  • SINGAPORE and DENVER, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Cerecin, Inc. a clinical-stage biotechnology company pioneering innovative neurotherapeutics, today announced that a poster showcasing new data on investigational CER-0001 (tricaprilin) in Infantile Spasms (also known as West Syndrome) has been accepted for virtual oral presentation at the hybrid International League Against Epilepsy EME Congress, held in Riyadh from November 16-19, 2022.
  • The data will be presented by Cerecins Chief Medical Officer, Dr. Marc Cantillon.
  • Cerecin is supported by two multinational partners, Nestle S.A. (NSRGY), and Wilmar International Limited (F34.SI).
  • CER-0001, also known as tricaprilin, is a specific medium chain triglyceride that Cerecin is developing for a range of neurological indications including Alzheimers disease, migraine and infantile spasms.

Ketosis and Rebound COVID: Keto5 Files for Patent for Its Exogenous Ketone Salt Products as an Adjunct Supplement for Licensed COVID Treatment Paxlovid, Which May Help Reduce Rebound COVID Cases

Retrieved on: 
Wednesday, August 24, 2022
Nervous system, University, CEO, Immunity, Brain, Disease, Virus, Glucose, Food, Ketosis, Cell, Patent, Warburg effect (oncology), Traffic barrier, HIV, Criticism of the Food and Drug Administration, Immune system, Cedars-Sinai Medical Center, Warburg effect, Ketone bodies, SARS, Spinal cord, Industry, Health, COVID, HIV/AIDS, Viral load, Patient, Vaccine, Pharmaceutical industry, Animal

BEVERLY HILLS, Calif., Aug. 24, 2022 /PRNewswire/ -- Keto5, (https://keto5.com/ ), a doctor-founded Beverly Hills-based company, has filed for a patent for the use of its proprietary exogenous ketone salt products as an adjunct supplement for the licensed COVID treatment Paxlovid as it might possibly reduce the frequency of reoccurring COVID cases experienced in some patients once having completed the standard course of Paxlovid.

Key Points: 
  • COVID reoccurrences after having taken anti-virals such as Paxlovid have become a growing concern highlighted by the recent high-profile cases of President Joe Biden and Dr. Anthony Fauci.
  • A recent study led by the University of Bonn (Germany), points to energy-rich molecules -- ketone bodies -- possibly helping the body to cope better with viruses.
  • Keto5 is a physician-founded company that will revolutionize how we achieve renewed health through the natural power of ketosis.
  • Keto5 products are not intended to diagnose, treat, cure or prevent any disease.

New Study: Active Ingredient in Metabolic Switch Induces Ketosis

Retrieved on: 
Monday, April 18, 2022
Ageing, Buck Institute for Research on Aging, Association, MD, Isle, Doctor of Philosophy, Cell, Blood, Ketosis, Ketone bodies, BHB, Journal, BIS, History, Fasting, Research, Ketone, Drinking, Partnership, Health, Therapy, C6, Soft drink, Dietary supplement, Pharmaceutical industry, Amazon

DOUGLAS, Isle of Man, April 18, 2022 /PRNewswire/ -- A recent study published in the Journal of American Nutrition Association shows that bis hexanoyl (R)-1,3-butanediol (BH-BD), the active ingredient in Metabolic Switch, induces ketosis.

Key Points: 
  • DOUGLAS, Isle of Man, April 18, 2022 /PRNewswire/ -- A recent study published in the Journal of American Nutrition Association shows that bis hexanoyl (R)-1,3-butanediol (BH-BD), the active ingredient in Metabolic Switch, induces ketosis.
  • Researchers studied the beverage form of Metabolic Switch to determine whether consumption of BH-BD effectively induces exogenous ketosis in healthy adults at rest within thirty minutes.
  • Metabolic Switch is available in unflavored powder, which can be mixed into a beverage or health drink, and ready to drink in Chocolate Nitro flavor, for ketosis on the go.
  • Both Metabolic Switch Powder ($49.99) and Metabolic Switch Drink ($34.99) are available on juvlabs.com and Amazon.

Drinking Ketones Daily: 10-Day Drink Ketones Challenge Is the Quickest, Easiest Way to Experience Ketosis in Body and Mind

Retrieved on: 
Thursday, October 21, 2021
Drinking, Ketosis, Carbohydrate, Glucose, Fats, Brain, Food, Appetite, Ketone bodies, Facebook, Lunch, Ketone, Hunger, Muscle, Meal, Liver, Milk, Dietary supplement

Did you know that you can give your body and mind the experience of ketosis by simply drinking ketones?

Key Points: 
  • Did you know that you can give your body and mind the experience of ketosis by simply drinking ketones?
  • Bill and Erica Schultz are Independent Promoters for the Pruvit nutritional supplements and are excited to invite you to try the 10-Day Drink Ketones Challenge.
  • The challenge, available at Drinking Ketones Daily, provides you with daily Pruvit Ketones supplements that you can mix straight from a packet.
  • As long as the meals are low carb, the supplements will put your body and mind into a state of ketosis.